Quantitative assessment of truncal FDG-PET examination with postinjection transmission scan--comparison with preinjection transmission scan.
The purpose of this study was to assess the quantitative accuracy of truncal FDG PET with a postinjection transmission scan.


METHODS
Ten subjects with lung cancer were recruited for this study. Prior to the emission scan, a transmission scan was performed for 10 min. All subjects received 370 MBq of intravenous administration of FDG prior to a 60-min emission scan. Immediately following the emission scan, a postinjection transmission scan was performed. Emission data from 40 to 60 min postinjection were reconstructed with either pre- or postinjection transmission data and converted to a standardized uptake value (SUV) image. On each SUV image, 5 regions of interest were placed and regions of interest on the SUV image with a postinjection transmission scan (SUVpost) were plotted against those with preinjection transmission (SUVpre), and a regression line was generated. Using the slope and Y-intercept of the regression line, percent error of estimation of the SUV was calculated based on the following equation: % error = ISUVpre - SUVpostI x 100/SUVpre.


RESULTS
In the low SUV area (SUV = 1), the averaged percent error was 9.4 +/- 12.0% (mean +/- SD), whereas in the high SUV area (SUV = 10), the averaged percent error was 2.8 +/- 3.1%. The least percent error was 1.8 +/- 1.8% (SUV = 3.8) in this study.


CONCLUSIONS
In the study on truncal FDG PET with postinjection transmisson scan, the quantitative accuracy was preserved and the method is clinically available.
Tsuchida
Tatsuro
T
Department of Radiology Faculty of Medicine, University of Fukui, Japan. tsucchy@fmsrsa.fukui-med.ac.jp
Sugimoto
Katsuya
K
Nishizawa
Sadahiko
S
Yonekura
Yoshiharu
Y
Itoh
Harumi
H
D000368:Aged; D000465:Algorithms; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000008:administration & dosage*; D006801:Humans; D007090:Image Interpretation, Computer-Assisted / Q000379:methods*; D007275:Injections, Intravenous; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000008:administration & dosage; D013382:Subtraction Technique
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18